| Huang, Ying |
Fred Hutchinson Cancer Center
United States |
Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies |
5R01CA277133-02 |
Nick Hodges, Ph.D. |
| Hu, Shuiying |
Ohio State University
United States |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
5R01CA238946-05 |
Rachel Altshuler, Ph.D. |
| Hu, Shuiying |
Ohio State University
United States |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
5R01CA238946-05 |
Rachel Altshuler, Ph.D. |
| Hu, Shuiying |
Ohio State University
United States |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
5R01CA238946-05 |
Rachel Altshuler, Ph.D. |
| Hu, Shuiying |
Ohio State University
United States |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
5R01CA238946-05 |
Rachel Altshuler, Ph.D. |
| Hu, Shuiying |
Ohio State University
United States |
Targeting neuronal transport to ameliorate vincristine neurotoxicity |
1R01CA272254-01A1 |
Rachel Altshuler, Ph.D. |
| Hu, Jim |
Weill Medical Coll Of Cornell Univ
United States |
Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL) |
5R01CA259173-02 |
Marjorie Perloff, M.D. |
| Hruska, Carrie B |
Mayo Clinic Rochester
United States |
Density MATTERS Clinical Trial |
5R01CA239200-04 |
Claire Zhu, Ph.D. |
| Houghton, A Mcgarry |
Fred Hutchinson Cancer Center
United States |
Tumor-specific autoantibodies for SCLC early detection |
5R01CA243328-06 |
Guillermo Marquez, Ph.D. |
| Hoshida, Yujin |
Ut Southwestern Medical Center
United States |
Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis |
1U01CA288375-01 |
|